KushnerI.The phenomenon of the acute phase response. Ann NY Acad Sci1982; 389: 39–48.
2.
BaumannHRichardsCGauldieJ.Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (Hep G2) cells. J Immunol1987; 139: 4122–8.
3.
GauldieJRichardsCHarnishDLansdorpPBaumannH.Interferon beta-2/B-cell stimulating factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA1987; 84: 7251–5.
4.
FontanaAWeberEDayerJM. Synthesis of interleukin-1/endogenous pyrogen in the brain of endotoxin treated mice: A step in fever induction. J Immunol1984; 133: 1696–8.
5.
StarnesHFWarrenRSJeevanandamMGabriloveJLLarchianW.Tumour necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest1988; 82: 1321–5.
6.
WhicherJTEvansSW. Cytokines in disease. Clin Chem1990; 36: 1269–81.
7.
WhicherJT. Functions of acute phase proteins in the inflammatory response. In: ArnaudPBienvenuJLaurentP, eds. Marker Proteins in Inflammation, Vol 2. Berlin and New York: Walter de Gruyter1984; 90–8.
8.
AronsenK-FEkelundGKindmarkC-OLaurellC-B.Sequential changes of plasma proteins after surgical trauma. Scand J Clin Lab Invest1972; 29 (suppl 124): 127–36.
9.
LaurellC-B.The use of electroimmunoassay for determining specific proteins as a supplement to agarose gel electrophoresis. J Clin Pathol1974; 28 (suppl 6): 22–6.
MorleyJJKushnerI.Serum C-reactive protein levels in disease. Ann NY Acad Sci1982; 389: 406–18.
12.
YorstonDWhicherJTChambersREKloudaPEastyD.The acute phase response in anterior uveitis. Trans Ophthalmol Soc UK1985; 104: 166–70.
13.
PepysMB. Serum C-reactive protein, serum amyloid-P component and serum amyloid A protein in autoimmune disease. Clin Immunol Allergy1981; 1: 77–101.
14.
KushnerIMackiewiczA.Acute phase proteins as disease markers. Disease Markers1987; 5: 1–11.
15.
ChambersREHuttonCWDieppePAWhicherJT. Comparative study of C-reactive protein and serum amyloid A protein in experimental inflammation. Ann Rheum Dis1991; 50: 677–9.
16.
ClausDROsmandAPGewurzH.Radioimmunoassay of human C-reactive protein and levels in normal sera. J Clin Lab Med1976; 87: 120–8.
17.
PeltolaHO. C-reactive protein for rapid monitoring of infections of the central nervous system. Lancet1982; i: 980–3.
18.
SalonenE-MVaheriA.C-reactive protein in acute viral infections. J Med Virol1981; 8: 161–7.
19.
WhicherJTChambersREHigginsonJNashefLHigginsPG. Acute phase response of serum amyloid A protein and C-reactive protein to the common cold and influenza. J Clin Pathol1985; 38: 312–16.
20.
CalvinJPriceCP. Measurement of serum alpha 1-antichymotrypsin by immunoturbidimetry. Ann Clin Biochem1986; 23: 206–9.
21.
LaurellC-B.Acute phase proteins—a group of protective proteins. In: PriceCPAlbertiKGMM, eds. Recent Advances in Clinical Biochemistry, Vol. 3. Edinburgh: Churchill Livingstone, 1985; 103–24.
22.
CarellRWOwenMC. Alpha 1-antitrypsin: Structure, variation in disease. Essays Med Biochem1979; 4: 83–119.
ChambersREStrossPBarryREWicherJT. Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest1987; 17: 460–7.
26.
FahraeusR.The suspension stability of blood. Acta Med Scand1921; 55: 1–228.
27.
StuartJWhicherJT. Tests for detecting and monitoring the acute phase reponse. Arch Dis Child1988; 63: 115–17.
28.
HutchinsonRMEasthamRD. A comparison of the erythrocyte sedimentation rate and plasma viscosity in detecting changes in plasma proteins. J Clin Pathol1977; 30: 345–9.
29.
MallyaRKBerryHMaceBEWDe BeerFCPepysMB. Diurnal variation of erythrocyte sedimentation rate related to feeding. Lancet1982; i: 389–90.
30.
International Committee for Standardisation in Haematology (Expert Panel on Blood Rheology). Guidelines on selection of laboratory tests for monitoring the acute phase response. J Clin Pathol1988; 41: 1203–12.
31.
JanoffA.Elastase in tissue injury. Annu Rev Med1985; 36: 207–16.
32.
BanksREEvansSWTaylorKFBirdHAWhicherJT. Measurement of plama concentrations of polymorpho-nuclear elastase—alpha-1-proteinase inhibitor (elastase—alpha-1-antitrypsin) in patients with rheumatoid arthritis: Interference by rheumatoid factor. Ann Rheum Dis1990; 49: 18–21.
33.
BorthWDunkyAKleesiekK.Alpha-2 macroglobulin-proteinase complexes as correlated with alpha-1 proteinase inhibitor-elastase complexes in synovial fluids of rheumatoid arthritis patients. Arthritis Rheum1986; 29: 319–25.
34.
AdeyemiEONeumannSChadwickVSHodgsonHJFPepysMB. Circulating human leukocyte elastase in patients with inflammatory bowel disease. Gut1985; 26: 1306–11.
35.
HopkinsSJHumphreysM.Simple, sensitive and specific bioassay of interleukin-1. J Immunol Methods1989; 120: 271–6.
36.
MeagerALeungHWoolleyJ.Assays for tumour necrosis factor and related cytokines. J Immunol Methods1989; 116: 1–17.
37.
Van OersMHJVan der HeydenAAPAMAardenLA. Interleukin 6(IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol1988; 71: 314–19.
38.
NijstenMWNde GrootERten DuisHJKlasenHJHackCEAardenLA. Serum levels of interleukin-6 and acute phase responses. Lancet1987; ii: 921.
39.
CannonJGvan der MeerJWMKwiatkowskiDInterleukin-1 beta in human plasma: Optimisation of blood collection, plasma extraction and radioimmunoassay methods. Lymphokine Res1988; 7: 457–67.
40.
WhaleyK. (ed). Complement in Health and Disease. Lancaster, UK: MTP Press, 1986.
41.
PeakmanMSendaliGVerganiD.Assessment of complement activation in clinical immunology laboratories: Time for reappraisal?J Clin Pathol1989; 42: 1018–25.
42.
SchofieldKPVoulgariFGozzardDILeylandMJBeechingNJStuartJ.C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia. J Clin Pathol1982; 35: 866–9.
43.
McConkeyBCrocksonRACrocksonAP. The assessment of rheumatoid arthritis. A study based on measurements of the serum acute phase reactants. Q J Med1972; 41: 115–25.
44.
MallyaRKDe BeerFCBerryHHamiltonEDMaceBEPepysMB. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentrations of C-reactive protein, and erythrocyte sedimentation rate. J Rheumatol1982; 9: 224–8.
45.
MallyaRKVerganiDTeeDEHBevisLDe BeerFCBerryHHamiltonEDBMaceBEWPepysMB. Correlation in rheumatoid arthritis of concentration of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity. Clin Exp Immunol1982; 48: 747–53.
46.
CowlingPEbringerRCandellDIshiiMEbringerA.C-reactive protein, ESR, and klebsiella in ankylosing spondylitis. Ann Rheum Dis1980; 39: 45–9.
47.
DixonJSBirdHASittonNGPickupMEWrightV.C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol1984; 13: 39–44.
48.
StuartJWhicherJT. Monitoring the acute-phase response-laboratory tests and clinical applications. In: DelamoreIWYinJA Liu, eds. Haematological Effects of Systemic Disease. London: Bailliere Tindall1990: 413–40.
49.
MallyaRKHindCRKBerryHPepysMB. Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study. Arthritis Rheum1985; 28: 383–7.
50.
ParkJRJonesJGHazlemanBL. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis1981; 40: 493–5.
51.
BeckerGJWaldburgerMHughesGRVPepysMB. Value of C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis1980; 39: 50–2.
52.
ter BorgEJHorstGLimburgPCvan RijswijkMHKallenbergCGM. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study. J Rheumatol1990; 17: 1642–8.
53.
CalvinJNealeGFotherlyKJPriceCP. The relative merits of acute phase proteins in the recognition of inflammatory conditions. Ann Clin Biochem1988; 25: 60–6.
54.
ShineBBerghouseLJonesJE LennardLandonJ.C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta1985; 148: 105–9.
55.
FaganEADyckRFMatonPNHodgsonHJFChadwickVSPetrieAPepysMB. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest1982; 12: 351–9.
56.
HawrylyshynPBernsteinPMilliganJESoldinSPollardAPapsinFR. Premature rupture of membranes: The role of C-reactive protein in the prediction of chorioamnionitis. Am J Obstet Gynecol1983; 147: 240–6.
57.
ShineBGouldJCampbellCHindochaPWilmotR PritcherWoodCBS. Serum C-reactive protein in normal and infected neonates. Clin Chim Acta1985; 148: 97–103.
58.
De BeerFCKirstenGGGieRPBeyersNStrachanAF. Value of C-reactive protein measurements in tuberculous, bacterial and viral meningitis. Arch Dis Child1984; 59: 653–6.
59.
SabelKGWadsworthC.C-reactive protein (CRP) in early diagnosis of neonatal septicaemia. Acta Paediatr Scand1979; 68: 825–31.
60.
StarkeIDDe BeerFCDonnellyJPCatovskyDGoldmanJMGaltonDAGPepysMB. Serum C-reactive protein levels in the management of infection in acute leukaemia. Eur J Cancer Clin Oncol1984; 20: 319–25.
61.
CrocksonRAPayneCJRatcliffAPSoothillJF. Time sequence of acute-phase reactant proteins following surgical trauma. Clin Chim Acta1966; 14: 435–41.
62.
ShakespearePGBallAJSpurrED. Serum protein changes after abdominal surgery. Ann Clin Biochem1989; 26: 49–57.
63.
JohanssonBGKindmarkCOTrellEWillheimFA. Sequential changes of plasma proteins after myocardial infarction. Scand J Clin Invest1972; 29: 117–24.
64.
WeinsteinPSSkinnerMSipeJDLokichJJZamcheckNCohenAS. Acute proteins or tumour markers: The role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol1984; 19: 193–8.
65.
GrothJKardenJHoffmanPMullerKMrochenHMebelM.C-reactive protein and clinical kidney transplantation. Nephron1984; 37: 236–9.
66.
MauryCPJTeppsAM. Comparative study of serum amyloid-related protein SAA, C-reactive protein and alpha-2 microglobulin as markers of renal allograft rejection. Clin Nephrology1984; 22: 289–92.
67.
WilhelmsenLSvardsuddKKorsan-BengtsenKLarrsonBWelinLTibblinG.Fibrinogen as a risk factor for stroke and myocardial infarction. New Engl J Med1984; 311: 501–5.